(Q40473325)

20 September 2017

Difficult to control atopic dermatitis (English)

1 reference

20 September 2017

1 reference

Ulf Darsow

1

1 reference

20 September 2017

Andreas Wollenberg

2

1 reference

20 September 2017

Dagmar Simon

3

1 reference

20 September 2017

Alain Taïeb

4

1 reference

20 September 2017

Thomas Werfel

5

1 reference

20 September 2017

Arnold Oranje

6

1 reference

20 September 2017

Carlo Gelmetti

7

1 reference

20 September 2017

Ake Svensson

8

1 reference

20 September 2017

Mette Deleuran

9

1 reference

20 September 2017

Anne-Marie Calza

10

1 reference

20 September 2017

Francesca Giusti

11

1 reference

20 September 2017

Jann Lübbe

12

1 reference

20 September 2017

Stefania Seidenari

13

1 reference

20 September 2017

Johannes Ring

14

1 reference

20 September 2017

European Task Force on Atopic Dermatitis / EADV Eczema Task Force

15

1 reference

20 September 2017

14 March 2013

1 reference

The World Allergy Organization Journal

20 September 2017

1 reference

20 September 2017

6

1 reference

20 September 2017

1

1 reference

20 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1186/1939-4551-6-6

20 September 2017

0 references

cites work

ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Atopic dermatitis: a disease caused by innate immune defects?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

What's new in atopic eczema? An analysis of the clinical significance of systematic reviews on atopic eczema published in 2006 and 2007.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Atopic dermatitis: systemic immunosuppressive therapy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Mycophenolate mofetil therapy for moderate to severe atopic dermatitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Efficacy and safety of 'wet-wrap' dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Secondary infections in patients with atopic dermatitis.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Macrolactam immunomodulators for topical treatment of inflammatory skin diseases

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Allergic contact dermatitis in children and adolescents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

High levels of fusidic acid-resistant Staphylococcus aureus in dermatology patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Topical steroids under wet-wrap dressings in atopic dermatitis--a vehicle-controlled trial

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Alefacept for moderate to severe atopic dermatitis: a pilot study in adults.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Mycophenolate mofetil is effective in the treatment of atopic dermatitis

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Cyclosporine in severe childhood atopic dermatitis: a multicenter study.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646539

Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment

20 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1939-4551-6-6

Contact sensitization in children

21 January 2018

1 reference

12 December 2020

Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis

1 reference

12 December 2020

Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study

1 reference

12 December 2020

Anti-CD20 (rituximab) treatment improves atopic eczema

1 reference

12 December 2020

Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group

1 reference

12 December 2020

Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis

1 reference

12 December 2020

Methotrexate for the treatment of adult atopic dermatitis

1 reference

12 December 2020

Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids

1 reference

12 December 2020

Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis

1 reference

12 December 2020

Proactive therapy of atopic dermatitis--an emerging concept

1 reference

12 December 2020

Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema

1 reference

12 December 2020

Staphylococcus aureus skin colonization in atopic dermatitis patients

1 reference

12 December 2020

Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study

1 reference

12 December 2020

Identifiers

DOI

10.1186/1939-4551-6-6

1 reference

Dimensions Publication ID

20 September 2017

1014470387

0 references

Fatcat ID

release_z4yfll46l5dfho3lbkrtozvea4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z4yfll46l5dfho3lbkrtozvea4

24 November 2022

mapped directly with Wikidata item

1 reference

20 September 2017

PubMed publication ID

23663504

1 reference